Mickie Griffith-Autry, PhD, NP-C
Mickie Griffith-Autry Article
Significant controversy around medical treatment modalities for the relief of menopausal symptoms is present. Currently three modes of therapy are used and include hormone therapy, selective estrogen receptor therapy, and antidepressants.
Hormone therapy is initiated for the primary complaints of hot flashes, night sweats and vaginal atrophy. It is important to note that hormone therapy is effective in the prevention of osteoporosis in menopausal women. Hormone therapy currently consists of estrogens, progesterone, or a combination of both. Hormone therapy can be administered in three forms, oral, sprays, gels, patches, or inserted vaginal rings.
Selective estrogen receptor therapy are non-hormonal and bind with estrogen receptor sites, produce estrogen-like effects in certain tissues, and produce estrogen-blocking effects in other tissues (such as breasts) and organs. These medications are indicated for the treatment and prevention of osteoporosis.
Antidepressant therapy specifically Effexor ®, Paxil ®, and Prozac ® are another form of therapy for the treatment of hot flashes and mood changes. The research available on their effectiveness in treating menopausal symptoms is limited however some reports indicate some symptoms relief.
It is imperative that the menopausal women who suffers from hot flashes, night sweats, and emotional disturbances see her health care provider. If these symptoms are interfering with quality of life, help is available.
Ms. Autry earned her Bachelor of Science degree in nursing from Jacksonville State University, her Masters of Science degree in nursing from the University of Alabama Huntsville, and her PhD from Walden University. Her research dissertation was entitled Pelvic muscle strengthening: Impact on sexual functioning in the menopausal woman. Ms. Autry is certified by the American Academy of Nurse Practitioners, the American Nursing Credentialing Center, and the Certification Board for Urological Nurses and Associates. She has completed multiple postgraduate preceptor programs in female sexual medicine, pelvic pain, and pelvic floor dysfunction. Ms. Autry is an active member of the Society of Urological Nurse Associates, North American Menopause Society, American Urological Society, and the International Pelvic Pain Society and founder of two women's health support groups. She is a national and local speaker for multiple pharmaceutical and medical companies, has participated in clinical trial studies, and has published articles in the Society of Urological Nurse Associate and North American Menopause Society journals.
Mickie Griffith-Autry, PhD, NP-C |